Catalyst Wire Dossier Catalyst Wire Dossier

Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (A, C, Y, W-135) · JN-International Medical Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine, covering 2015-04-23 to 2015-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine [Phase 2]

See pricing